PROJECT 1: Assessing and modulating the role of inflammation and fibrosis in the dystrophic process. Project 1 will follow the fate of satellite cells during the progression of disease in mdx and A/J mice, while characterizing changes in muscular tissue, fibrosis and fat. The project will go on to analyze inhibitors of inflammation and/or fibrosis and their impact on disease pathology in mdx and A/J mice. Lastly, the project will examine the combined effects of combined anti-inflammatory or anti-fibrotic drugs and myostatin inhibitors. The fundamental concept driving this project is that limiting fibrosis in the muscular dystrophies will help extend the period of successful regeneration via the patients own satellite cell repair, increase the benefits associated with therapies that increase the patients'muscle repair capacity, and will extend the age at which patients can benefit from eventual viral gene or stem cell therapies. Thus the primary objectives of this project are the attainment of clinically useful pharmacological means of inhibiting fibrosis by identifying the best existing pharmacological inhibitors of fibrosis, as well as driving the development of new classes of inhibitors.

Public Health Relevance

Fibrosis ultimately limits repair of skeletal muscle in the muscular dystrophies and will limit the success of viral gene transfer and stem cell therapies. By slowing fibrosis, the overall disease progression can be slowed and functional muscle can be better maintained and treated

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54AR052646-10
Application #
8722304
Study Section
Special Emphasis Panel (ZNS1-SRB-S)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
10
Fiscal Year
2014
Total Cost
$387,985
Indirect Cost
$136,497
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Posey Jr, Avery D; Swanson, Kaitlin E; Alvarez, Manuel G et al. (2014) EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development. Dev Biol 387:179-90
Villalta, S Armando; Rosenthal, Wendy; Martinez, Leonel et al. (2014) Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy. Sci Transl Med 6:258ra142
Moorwood, Catherine; Barton, Elisabeth R (2014) Caspase-12 ablation preserves muscle function in the mdx mouse. Hum Mol Genet 23:5325-41
Dorn 2nd, Gerald W; McNally, Elizabeth M (2014) Two strikes and you're out: gene-gene mutation interactions in HCM. Circ Res 115:208-10
Swaggart, Kayleigh A; McNally, Elizabeth M (2014) Modifiers of heart and muscle function: where genetics meets physiology. Exp Physiol 99:621-6
Ermolova, N V; Martinez, L; Vetrone, S A et al. (2014) Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function. Neuromuscul Disord 24:583-95
Smith, Lucas R; Barton, Elisabeth R (2014) Collagen content does not alter the passive mechanical properties of fibrotic skeletal muscle in mdx mice. Am J Physiol Cell Physiol 306:C889-98
Fahrenbach, John P; Andrade, Jorge; McNally, Elizabeth M (2014) The CO-Regulation Database (CORD): a tool to identify coordinately expressed genes. PLoS One 9:e90408
Puckelwartz, Megan J; Pesce, Lorenzo L; Nelakuditi, Viswateja et al. (2014) Supercomputing for the parallelization of whole genome analysis. Bioinformatics 30:1508-13
Forbes, Sean C; Willcocks, Rebecca J; Triplett, William T et al. (2014) Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study. PLoS One 9:e106435

Showing the most recent 10 out of 60 publications